The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
These dynamics can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. That said, here is one stock under $50 that could 10x and two best left ignored.
Two Stocks Under $50 to Sell:
Sensata Technologies (ST)
Share Price: $35.17
Originally a temperature sensor control maker and a subsidiary of Texas Instruments for 60 years, Sensata Technology Holdings (NYSE: ST) is a leading supplier of analog sensors used in industrial and transportation applications, best known for its dominant position in the tire pressure monitoring systems in cars.
Why Should You Dump ST?
- Sales tumbled by 4.4% annually over the last two years, showing market trends are working against its favor during this cycle
- Projected sales growth of 3% for the next 12 months suggests sluggish demand
- Gross margin of 29.3% reflects its high production costs
At $35.17 per share, Sensata Technologies trades at 9.7x forward P/E. Check out our free in-depth research report to learn more about why ST doesn’t pass our bar.
Select Medical (SEM)
Share Price: $16.29
With a nationwide network spanning 46 states and over 2,700 healthcare facilities, Select Medical (NYSE: SEM) operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers across the United States.
Why Are We Wary of SEM?
- Declining admissions over the past two years suggest it might have to lower prices to accelerate growth
- Performance over the past five years shows each sale was less profitable, as its earnings per share fell by 9.3% annually
- 6× net-debt-to-EBITDA ratio shows it’s overleveraged and increases the probability of shareholder dilution if things turn unexpectedly
Select Medical’s stock price of $16.29 implies a valuation ratio of 13.1x forward P/E. Dive into our free research report to see why there are better opportunities than SEM.
One Stock Under $50 to Buy:
GitLab (GTLB)
Share Price: $22.30
With its all-remote workforce pioneering a new approach to software development, GitLab (NASDAQ: GTLB) provides a single-application DevSecOps platform that helps development, operations, and security teams collaborate to build, secure, and deploy software faster.
Why Should You Buy GTLB?
- Ability to secure long-term commitments with customers is evident in its 26.4% ARR growth over the last year
- 120% net revenue retention rate indicates success in expanding revenue within existing accounts
- Prominent and differentiated software leads to a best-in-class gross margin of 87.4%
GitLab is trading at $22.30 per share, or 3.3x forward price-to-sales. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
